Trial intelligence / Profile preview

SEDCOM: Dexmedetomidine vs Midazolam for ICU Sedation

NCT00216190Phase 4Completed

Sponsor
Pfizer
Start
Mar 2005
Modality
Small Molecules
Countries
5
01

Overview

A Phase 4 trial of dexmedetomidine in sedation, sponsored by Pfizer. Started Mar 2005; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

sedation

Beyond the preview

Go deeper on NCT00216190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00216190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call